BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
POSTED
12-02-10
/PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its new BD - Canada corporate office in Mississauga received Gold Certification from the Canada Green Building Council Leadership in Energy and En...
POSTED
10-25-10
/PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has ranked among the top 25 companies in Newsweek's second annual "Green Rankings" of the 500 largest U.S. corporations based on environmental ...
POSTED
06-03-10
/PRNewswire-FirstCall/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2009 Sustainability Report. The report reaffirms the commitment of BD's 29,000 dedicated associates worldwide...
POSTED
03-05-10
/PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been selected by FORTUNE Magazine as one of the World's Most Admired Companies and ranked #1 in the Medical and Other Precision Equipment category, according to it...
POSTED
01-27-10
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is increasing the supply of its products available for donation in support of Haiti earthquake relief efforts from the $500,000 announced on January 15 to $5 million in market value ...
POSTED
01-15-10
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it is donating $550,000 in support of relief efforts to assist the victims of the earthquake in Haiti. A financial donation of $250,000 will be split equally bet...
POSTED
01-08-10
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has praised the recent announcement that the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) will increase its emphasis over the next five years on strengthening health syst...
POSTED
08-04-09
Aug. 4 /PRNewswire/ - BD (Becton, Dickinson and Company) and Direct Relief International announced today the launch of a new nationwide program to help people with insulin-dependent diagnosed diabetes who have been affected by the current economic crisis to manage the diseas...
POSTED
05-08-09
May 8 /PRNewswire-FirstCall/ -- Two days before Mother's Day, BD (Becton, Dickinson and Company), a leading global medical technology company, announced its continued support for the United Nations Children's Fund (UNICEF) campaign to vaccinate mothers and children in develo...
POSTED
03-11-09
March 11 /PRNewswire/ -- BD, a leading global medical technology company, announced today that its new BD Biosciences facility in San Jose has received Silver certification under the U.S. Green Building Council LEED (Leadership in Energy & Environmental Design) green bui...